17-68542277-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_017565.4(FAM20A):c.929-112C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 1,154,794 control chromosomes in the GnomAD database, including 11,457 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1396 hom., cov: 32)
Exomes 𝑓: 0.14 ( 10061 hom. )
Consequence
FAM20A
NM_017565.4 intron
NM_017565.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.493
Genes affected
FAM20A (HGNC:23015): (FAM20A golgi associated secretory pathway pseudokinase) This locus encodes a protein that is likely secreted and may function in hematopoiesis. A mutation at this locus has been associated with amelogenesis imperfecta and gingival hyperplasia syndrome. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Aug 2011]
PRKAR1A (HGNC:9388): (protein kinase cAMP-dependent type I regulatory subunit alpha) cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 17-68542277-G-A is Benign according to our data. Variant chr17-68542277-G-A is described in ClinVar as [Benign]. Clinvar id is 1237093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.134 AC: 20316AN: 152022Hom.: 1396 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
20316
AN:
152022
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.138 AC: 138355AN: 1002654Hom.: 10061 AF XY: 0.140 AC XY: 71572AN XY: 509906 show subpopulations
GnomAD4 exome
AF:
AC:
138355
AN:
1002654
Hom.:
AF XY:
AC XY:
71572
AN XY:
509906
Gnomad4 AFR exome
AF:
AC:
2928
AN:
23844
Gnomad4 AMR exome
AF:
AC:
5826
AN:
34346
Gnomad4 ASJ exome
AF:
AC:
2547
AN:
21708
Gnomad4 EAS exome
AF:
AC:
5707
AN:
34406
Gnomad4 SAS exome
AF:
AC:
13447
AN:
70354
Gnomad4 FIN exome
AF:
AC:
4701
AN:
43884
Gnomad4 NFE exome
AF:
AC:
96552
AN:
724404
Gnomad4 Remaining exome
AF:
AC:
6151
AN:
44808
Heterozygous variant carriers
0
6217
12434
18651
24868
31085
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2962
5924
8886
11848
14810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.134 AC: 20320AN: 152140Hom.: 1396 Cov.: 32 AF XY: 0.134 AC XY: 9950AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
20320
AN:
152140
Hom.:
Cov.:
32
AF XY:
AC XY:
9950
AN XY:
74386
Gnomad4 AFR
AF:
AC:
0.122999
AN:
0.122999
Gnomad4 AMR
AF:
AC:
0.154103
AN:
0.154103
Gnomad4 ASJ
AF:
AC:
0.120104
AN:
0.120104
Gnomad4 EAS
AF:
AC:
0.169822
AN:
0.169822
Gnomad4 SAS
AF:
AC:
0.198172
AN:
0.198172
Gnomad4 FIN
AF:
AC:
0.105114
AN:
0.105114
Gnomad4 NFE
AF:
AC:
0.133266
AN:
0.133266
Gnomad4 OTH
AF:
AC:
0.130435
AN:
0.130435
Heterozygous variant carriers
0
910
1821
2731
3642
4552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
649
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at